vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Palomar Holdings, Inc. (PLMR). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $253.4M, roughly 1.9× Palomar Holdings, Inc.). On growth, Palomar Holdings, Inc. posted the faster year-over-year revenue change (62.7% vs -1.7%). Over the past eight quarters, Palomar Holdings, Inc.'s revenue compounded faster (46.2% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Palomar Holdings, Inc. is a specialty insurance holding company that primarily provides property insurance products for catastrophe-exposed residential and commercial assets. It mainly operates across the United States, focusing on core segments including earthquake, flood, and windstorm coverage to meet high-risk property protection demands of customers.
MD vs PLMR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $253.4M |
| Net Profit | $33.7M | — |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 28.7% |
| Net Margin | 6.8% | — |
| Revenue YoY | -1.7% | 62.7% |
| Net Profit YoY | 10.5% | — |
| EPS (diluted) | $0.40 | $2.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $253.4M | ||
| Q3 25 | $492.9M | $244.7M | ||
| Q2 25 | $468.8M | $203.3M | ||
| Q1 25 | $458.4M | $174.6M | ||
| Q4 24 | $502.4M | $155.8M | ||
| Q3 24 | $511.2M | $148.5M | ||
| Q2 24 | $504.3M | $131.1M | ||
| Q1 24 | $495.1M | $118.5M |
| Q4 25 | $33.7M | — | ||
| Q3 25 | $71.7M | $51.5M | ||
| Q2 25 | $39.3M | $46.5M | ||
| Q1 25 | $20.7M | $42.9M | ||
| Q4 24 | $30.5M | — | ||
| Q3 24 | $19.4M | $30.5M | ||
| Q2 24 | $-153.0M | $25.7M | ||
| Q1 24 | $4.0M | $26.4M |
| Q4 25 | 9.9% | 28.7% | ||
| Q3 25 | 13.8% | 27.4% | ||
| Q2 25 | 12.8% | 29.5% | ||
| Q1 25 | 7.0% | 30.8% | ||
| Q4 24 | 7.8% | 28.9% | ||
| Q3 24 | 6.6% | 25.9% | ||
| Q2 24 | -31.3% | 25.5% | ||
| Q1 24 | 3.2% | 29.0% |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 14.5% | 21.0% | ||
| Q2 25 | 8.4% | 22.9% | ||
| Q1 25 | 4.5% | 24.6% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 3.8% | 20.5% | ||
| Q2 24 | -30.3% | 19.6% | ||
| Q1 24 | 0.8% | 22.3% |
| Q4 25 | $0.40 | $2.05 | ||
| Q3 25 | $0.84 | $1.87 | ||
| Q2 25 | $0.46 | $1.68 | ||
| Q1 25 | $0.24 | $1.57 | ||
| Q4 24 | $0.37 | $1.29 | ||
| Q3 24 | $0.23 | $1.15 | ||
| Q2 24 | $-1.84 | $1.00 | ||
| Q1 24 | $0.05 | $1.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $106.9M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $942.7M |
| Total Assets | $2.2B | $3.1B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $106.9M | ||
| Q3 25 | $340.1M | $111.7M | ||
| Q2 25 | $224.7M | $81.3M | ||
| Q1 25 | $99.0M | $119.3M | ||
| Q4 24 | $229.9M | $80.4M | ||
| Q3 24 | $103.8M | $86.5M | ||
| Q2 24 | $19.4M | $47.8M | ||
| Q1 24 | $8.0M | $61.4M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $942.7M | ||
| Q3 25 | $890.7M | $878.1M | ||
| Q2 25 | $833.8M | $847.2M | ||
| Q1 25 | $789.2M | $790.4M | ||
| Q4 24 | $764.9M | $729.0M | ||
| Q3 24 | $732.5M | $703.3M | ||
| Q2 24 | $706.5M | $532.6M | ||
| Q1 24 | $856.2M | $501.7M |
| Q4 25 | $2.2B | $3.1B | ||
| Q3 25 | $2.2B | $2.9B | ||
| Q2 25 | $2.1B | $2.8B | ||
| Q1 25 | $2.0B | $2.4B | ||
| Q4 24 | $2.2B | $2.3B | ||
| Q3 24 | $2.1B | $2.3B | ||
| Q2 24 | $2.0B | $2.0B | ||
| Q1 24 | $2.2B | $1.9B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $409.1M |
| Free Cash FlowOCF − Capex | — | $409.0M |
| FCF MarginFCF / Revenue | — | 161.4% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $700.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $409.1M | ||
| Q3 25 | $137.3M | $83.6M | ||
| Q2 25 | $137.2M | $120.9M | ||
| Q1 25 | $-117.5M | $87.2M | ||
| Q4 24 | $133.0M | $261.2M | ||
| Q3 24 | $91.8M | $100.3M | ||
| Q2 24 | $107.0M | $55.1M | ||
| Q1 24 | $-125.2M | $33.1M |
| Q4 25 | — | $409.0M | ||
| Q3 25 | — | $83.6M | ||
| Q2 25 | — | $120.8M | ||
| Q1 25 | — | $87.1M | ||
| Q4 24 | — | $260.9M | ||
| Q3 24 | — | $100.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 161.4% | ||
| Q3 25 | — | 34.2% | ||
| Q2 25 | — | 59.4% | ||
| Q1 25 | — | 49.9% | ||
| Q4 24 | — | 167.5% | ||
| Q3 24 | — | 67.4% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 1.63× | ||
| Q2 25 | 3.49× | 2.60× | ||
| Q1 25 | -5.66× | 2.03× | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 3.29× | ||
| Q2 24 | — | 2.14× | ||
| Q1 24 | -31.03× | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PLMR
Segment breakdown not available.
